OPKO Health Other Long-Term Assets 2010-2025 | OPK

OPKO Health other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
OPKO Health Annual Other Long-Term Assets
(Millions of US $)
2024 $214
2023 $204
2022 $204
2021 $600
2020 $600
2019 $597
2018 $643
2017 $653
2016 $650
2015 $797
2014 $799
2013 $800
2012 $14
2011 $1
2010 $0
2009 $0
OPKO Health Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $214
2024-12-31 $214
2024-09-30 $214
2024-06-30 $203
2024-03-31 $204
2023-12-31 $204
2023-09-30 $204
2023-06-30 $204
2023-03-31 $203
2022-12-31 $204
2022-09-30 $205
2022-06-30 $204
2022-03-31 $9
2021-12-31 $600
2021-09-30 $599
2021-06-30 $600
2021-03-31 $600
2020-12-31 $600
2020-09-30 $596
2020-06-30 $598
2020-03-31 $597
2019-12-31 $597
2019-09-30 $641
2019-06-30 $639
2019-03-31 $639
2018-12-31 $643
2018-09-30 $656
2018-06-30 $651
2018-03-31 $652
2017-12-31 $653
2017-09-30 $687
2017-06-30 $685
2017-03-31 $684
2016-12-31 $650
2016-09-30 $651
2016-06-30 $610
2016-03-31 $798
2015-12-31 $797
2015-09-30 $915
2015-06-30 $818
2015-03-31 $798
2014-12-31 $799
2014-09-30 $798
2014-06-30 $798
2014-03-31 $800
2013-12-31 $800
2013-09-30 $800
2013-06-30 $206
2013-03-31 $206
2012-12-31 $14
2012-09-30 $2
2012-06-30 $1
2012-03-31 $1
2011-12-31 $1
2011-09-30 $1
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.023B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $182.564B 79.96
Thermo Fisher Scientific (TMO) United States $150.197B 18.17
Edwards Lifesciences (EW) United States $43.309B 28.40
IDEXX Laboratories (IDXX) United States $42.135B 48.42
Alcon (ALC) Switzerland $42.123B 28.47
DexCom (DXCM) United States $31.369B 48.49
IQVIA Holdings (IQV) United States $26.768B 14.99
Mettler-Toledo (MTD) United States $23.982B 28.52
STERIS (STE) Ireland $23.183B 25.53
Waters (WAT) United States $20.390B 28.77
SONOVA HOLDING (SONVY) Switzerland $17.638B 0.00
Hologic (HOLX) United States $14.369B 15.61
Sysmex ADR (SSMXY) Japan $10.550B 29.93
Penumbra (PEN) United States $9.948B 78.08
Masimo (MASI) United States $8.956B 33.04
Globus Medical (GMED) United States $7.834B 18.67
Glaukos (GKOS) United States $5.723B 0.00
Teleflex (TFX) United States $5.228B 8.63
TransMedics (TMDX) United States $4.179B 90.85
Integer Holdings (ITGR) United States $4.110B 21.54
PROCEPT BioRobotics (PRCT) United States $3.332B 0.00
LivaNova (LIVN) United Kingdom $2.481B 14.78
Nihon Kohden (NHNKY) Japan $2.265B 25.98
Veracyte (VCYT) United States $2.067B 29.00
Elekta AB (EKTAY) Sweden $1.901B 17.09
Alphatec Holdings (ATEC) United States $1.599B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.292B 121.00
Pulse Biosciences (PLSE) United States $1.029B 0.00
Integra LifeSciences Holdings (IART) United States $0.901B 4.79
Beta Bionics (BBNX) United States $0.776B 0.00
IRadimed (IRMD) United States $0.741B 37.57
SiBone (SIBN) United States $0.698B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.561B 8.73
RxSight (RXST) United States $0.553B 0.00
Mesa Laboratories (MLAB) United States $0.523B 12.25
OrthoPediatrics (KIDS) United States $0.493B 0.00
Delcath Systems (DCTH) United States $0.482B 0.00
AxoGen (AXGN) United States $0.443B 0.00
AngioDynamics (ANGO) United States $0.407B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.405B 0.00
Semler Scientific (SMLR) United States $0.403B 10.72
Pacific Biosciences Of California (PACB) United States $0.381B 0.00
Treace Medical Concepts (TMCI) United States $0.347B 0.00
NeuroPace (NPCE) United States $0.341B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
908 Devices (MASS) United States $0.263B 0.00
Tactile Systems Technology (TCMD) United States $0.232B 14.04
Neuronetics (STIM) United States $0.228B 0.00
Sight Sciences (SGHT) United States $0.210B 0.00
Alpha Tau Medical (DRTS) Israel $0.204B 0.00
Biosig Technologies (BSGM) United States $0.183B 0.00
Inogen (INGN) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
CVRx (CVRX) United States $0.153B 0.00
Anteris Technologies Global (AVR) Australia $0.147B 0.00
LENSAR (LNSR) United States $0.146B 0.00
Rapid Micro Biosystems (RPID) United States $0.146B 0.00
Lucid Diagnostics (LUCD) United States $0.136B 0.00
Accuray (ARAY) United States $0.126B 0.00
Atossa Genetics (ATOS) United States $0.102B 0.00
Monogram Orthopaedics (MGRM) United States $0.100B 0.00
Microbot Medical (MBOT) United States $0.088B 0.00
Sensus Healthcare (SRTS) United States $0.078B 47.30
InspireMD (NSPR) United States $0.075B 0.00
EnVVeno Medical (NVNO) United States $0.071B 0.00
EDAP TMS S.A (EDAP) France $0.063B 0.00
Spectral AI (MDAI) United States $0.055B 0.00
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.050B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Baird Medical Investment Holdings (BDMD) $0.043B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
NexGel (NXGL) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Ekso Bionics Holdings (EKSO) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.32